AHL Partners’s Ligand Pharmaceuticals LGND Stock Holding History

AHL Partners’s Portfolio LGND Stock Details LGND Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$1.11M	Buy
2017 Q2	$443K	Buy
2016 Q1	–	Sell
2015 Q4	$2.09M	Buy
2015 Q3	$358K	Sell
2015 Q2	$4.77M	Buy